-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
-
Summary
-
Elite Pharmaceuticals Inc /Nv/ quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q1 2014 to Q1 2024.
- Elite Pharmaceuticals Inc /Nv/ Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending March 31, 2024 was $15.5M, a 11.8% decline year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)